Shellers Honored at Mural Arts Philadelphia’s 2021 Wall Ball
Stephen and Sandy Sheller were honorary attendees at Mural Arts Philadelphia’s 2021 Wall Ball, The Art of Wellbeing. Held virtually June 10, 2021 at 6:00 pm. The Sheller’s have been a long time supporter of Mural Arts’ Philadelphia’s First Same Day Pay Program, “Color Me Back.” The program has been successful addressing the growing problem […]
U.S. Supreme Court Declines J&J Appeal of $70M Risperdal Verdict
Johnson & Johnson is out of options after the U.S. Supreme Court declined to hear the pharmaceutical company’s appeal of a $70 million Risperdal verdict. In the cases of Yount vs. Janssen Pharmaceuticals, the 2019 Superior Court of Pennsylvania ruling stands. Yount’s doctor prescribed Risperdal off-label to address behavioral problems associated with autism when he […]
CEOs Receive Massive Bonuses Despite Ethics Scandals, Pass Cost on to Shareholders
When executive compensation is tied solely to short term profits, and not balanced against company payouts for wrongdoing, there’s an increased incentive for executive fraud. Recently Wells Fargo bank made headlines when bank employees opened million of fake accounts in customer’s names to meet quotas. Wells Fargo CEO testified before congress and passed the blame […]
Stephen Sheller Honored as The Legal’s 2020 Pennsylvania Trailblazer
2020 Pennsylvania Trailblazers brought to you by The Legal Intelligencer Watch: Deadly Drugs – Johnson & Johnson’s Risperdal
Health and Life Science Litigation in 2021
With the Biden administration taking the White House last month, the new administration has been vocal about enforcing antitrust and fraud laws, especially as it pertains to those who took advance of federal pandemic relief funds. According to Bloomberg Law’s Expect Turbocharged Enforcement Under a Biden DOJ, the new administration’s DOJ will likely be “increasing corporate […]
Purdue Pleads Guilty to Felonies, Plea Deal Receives Criticism
Purdue Pharma pleads guilty to criminal charges for illegal marketing of the its highly addictive painkiller, OxyContin. Corporations often pay penalties and fines for wrongdoing, yet criminal charges are rare. These charges include felony charges of defrauding federal health agencies and violating anti-kickback laws. The company also paid civil penalties for violating the False Claims […]
PA Supreme Court Upholds $70 Million Risperdal Verdict
The Pennsylvania Supreme Court has denied Johnson & Johnson’s request to overturn the $70 million Risperdal verdict upheld by a Superior court panel of judges last year. The case, A.Y. v. Janssen Pharmaceuticals, will now be remanded back to the PA Court of Common Pleas for a second trial to reconsider punitive damages. “We are […]
Appeals Court Upholds Block of Drug Pricing Transparency
A DC Circuit court upheld a federal judge’s ruling striking down the Department of Health and Human Services’ new rule requiring drug companies to disclose the price of a 30 day supply in advertising. Merck, Eli Lilly and Amgen argued that disclosing drug prices in advertisements violates their first amendment rights by controlling and compelling […]
Pharmacies Face New Suit In Opioids Crisis
A new court filing against big American pharmacy retailers has been submitted in the multi-district litigation in Ohio Federal Court overseen by Judge Dan Polster. The complaint accuses major pharmacies, including CVS, Rite Aid, Walgreens, Walmart and Giant Eagle of being complicit in perpetuating the crisis as manufactures and distributors of the addictive drugs. The […]
$8 Billion Risperdal Verdict Tops Legal News in 2019
April 2020 Update: Stephen Sheller has been recognized by the American Association for Justice with AAJ’s 2019 Top Verdict Award. “Each year, American Association for Justice releases the Top Verdicts Litigation Packet, featuring the opening statements and closing arguments from the previous year’s top cases. Congratulations on the impressive result you secured for your clients […]
